Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Oct 14, 2024. (Total: 232476Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 10 (of 10 Records)

Query Trace: Lung Neoplasms and SP1[original query]
A myeloperoxidase polymorphism associated with reduced risk of lung cancer.
Lung cancer (Amsterdam, Netherlands) 2002 Jul 37 (1): 35-40.
Schabath Matthew B, Spitz Margaret R, Hong Waun K, Delclos George L, Reynolds Wanda F, Gunn Gary B, Whitehead Lawrence W, Wu Xife
Point: myeloperoxidase -463G --> a polymorphism and lung cancer risk.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2002 Dec 11 (12): 1550-4.
Feyler Anne, Voho Anu, Bouchardy Christine, Kuokkanen Katja, Dayer Pierre, Hirvonen Ari, Benhamou Simo
Correlation between a single nucleotide polymorphism in the matrix metalloproteinase-2 promoter and risk of lung cancer.
Cancer research 2002 Nov 62 (22): 6430-3.
Yu Chunyuan, Pan Kaifeng, Xing Deyin, Liang Gang, Tan Wen, Zhang Lian, Lin Dongx
A novel T-77C polymorphism in DNA repair gene XRCC1 contributes to diminished promoter activity and increased risk of non-small cell lung cancer.
Oncogene 2006 Jun 25 (25): 3613-20.
Hao B, Miao X, Li Y, Zhang X, Sun T, Liang G, Zhao Y, Zhou Y, Wang H, Chen X, Zhang L, Tan W, Wei Q, Lin D, He
A variant of the Cockayne syndrome B gene ERCC6 confers risk of lung cancer.
Human mutation 2008 Jan 29 (1): 113-22.
Lin Zhongning, Zhang Xuemei, Tuo Jingsheng, Guo Yongli, Green Bridgett, Chan Chi-Chao, Tan Wen, Huang Ying, Ling Wenhua, Kadlubar Fred F, Lin Dongxin, Ning Baita
A variant in the CHEK2 promoter at a methylation site relieves transcriptional repression and confers reduced risk of lung cancer.
Carcinogenesis 2010 Jul 31 (7): 1251-8.
Zhang Shuyu, Lu Juan, Zhao Xueying, Wu Wenting, Wang Huibo, Lu Jun, Wu Qihan, Chen Xin, Fan Weiwei, Chen Hongyan, Wang Feng, Hu Zhibin, Jin Li, Wei Qingyi, Shen Hongbing, Huang Wei, Lu Da
MDM2 SNP285 does not antagonize the effect of SNP309 in lung cancer.
International journal of cancer. Journal international du cancer 2012 Dec 131 (11): 2710-6.
Ryan Bríd M, Calhoun Kara M, Pine Sharon R, Bowman Elise D, Robles Ana I, Ambs Stefan, Harris Curtis
Conserved recurrent gene mutations correlate with pathway deregulation and clinical outcomes of lung adenocarcinoma in never-smokers.
BMC medical genomics 2014 7 (1): 32.
Sun Zhifu, Wang Liang, Eckloff Bruce W, Deng Bo, Wang Yi, Wampfler Jason A, Jang JinSung, Wieben Eric D, Jen Jin, You Ming, Yang Pi
The rs1550117 A>G variant in DNMT3A gene promoter significantly increases non-small cell lung cancer susceptibility in a Han Chinese population.
Oncotarget 2017 Apr 8 (14): 23470-23478.
Wang Jingdong, Li Chade, Wan Fengting, Li Zhou, Zhang Jingli, Zhang Jiankun, Feng Xianhong, Tang Liang, Chen Bife
Genetic polymorphisms in CYP2B6 may be associated with lung cancer risk in the Chinese Han population.
Expert review of respiratory medicine 2024 1 1-9.
Xiaoya Ma, Xufeng Zang, Leteng Yang, Wenqian Zhou, Yujie Li, Jie Wei, Jinping Guo, Junhui Han, Jing Liang, Tianbo J
TOP